Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Operating Expenses | 12,752 | 8,628 | 6,054 | 4,380 | 4,769 |
| Operating Income | -12,752 | -8,628 | -6,054 | -4,380 | -4,769 |
| Interest Expense | 201 | 203 | 195 | 146 | 61 |
| Other Income | 0 | 6 | 0 | 0 | 0 |
| Pre-tax Income | -12,953 | -8,825 | -6,249 | -4,526 | -4,830 |
| Net Income Continuous | -12,953 | -8,825 | -6,249 | -4,526 | -4,830 |
| Net Income Discontinuous | N/A | 1,088 | 128 | -43 | -91 |
| Net Income | $-12,953 | $-7,737 | $-6,121 | $-4,569 | $-4,921 |
| EPS Basic Total Ops | -0.85 | -0.71 | -0.40 | -0.40 | -0.40 |
| EPS Basic Continuous Ops | -0.85 | -0.75 | -0.40 | -0.45 | -0.40 |
| EPS Basic Discontinuous Ops | N/A | 0.09 | 0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.85 | -0.71 | -0.40 | -0.40 | -0.40 |
| EPS Diluted Continuous Ops | -0.85 | -0.75 | -0.40 | -0.45 | -0.40 |
| EPS Diluted Discontinuous Ops | N/A | 0.09 | 0.01 | 0.00 | -0.01 |
| EBITDA(a) | $-12,552 | $-8,451 | $-5,875 | $-4,241 | $-4,678 |